Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial

Lignende værker

• Author Correction: First-line modified FOLFOX plus/minus nivolumab and Ipilimumab or FLOT plus nivolumab in advanced gastroesophageal adenocarcinoma: a phase II multi-cohort IKF-AIO-MOONLIGHT trial
  af: Sylvie Lorenzen, et al.
  Udgivet: (2026-04-01)
• Bilateral optic neuropathy in Krukenberg tumor treated with FOLFOX plus nivolumab: a case report
  af: Junwoo Lee, et al.
  Udgivet: (2025-04-01)
• The efficacy of combination immunotherapy with ipilimumab plus nivolumab in metastatic myxofibrosarcoma
  af: Foteini Kalofonou, et al.
  Udgivet: (2024-10-01)
• Efficacy and safety of taxane plus ramucirumab for advanced gastric cancer after chemotherapy plus nivolumab
  af: Toshihiko Matsumoto, et al.
  Udgivet: (2025-08-01)
• Comparative safety of nivolumab plus ipilimumab versus nivolumab plus relatlimab in advanced melanoma: a pharmacovigilance study based on the FDA adverse event reporting system (FAERS)
  af: Shanshan Xu, et al.
  Udgivet: (2025-07-01)